Nupharmisto Psoriasis Eczema Cream

Manufacturer
Ehy Holdings LLC
Effective date
2023-04-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:54:46

Label at a glance#

ProductNupharmisto Psoriasis Eczema Cream
Active ingredientMENTHA CANADENSIS TOP, VIOLA PHILIPPICA WHOLE, SOPHORA FLAVESCENS WHOLE, RHINACANTHUS NASUTUS LEAF, DICTAMNUS DASYCARPUS WHOLE, EUPHORBIA HIRTA, MURRAYA PANICULATA FRUIT
Label structure12 sections

Dosage and administration

Apply a small amount to theproblem areas with circularmotions for 3 minutes till theskin absorbs the cream.

Storage and handling

Store at 59-86ff(15-30°CClose the cap tightly after use.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

RHINACANTHUS NASUTUS 7%
DICTAMNUS DASYCARPUS TURCZ 7%
VIOLA PHILIPPICA 3%
EUPHORBIA HIRTA 2%
MURRAYA EXOTICA 2%
SOPHORA FLAVESCENS ALT 1.8%
MENTHA HAPLOCALYX BRIQ 1.2%

Purpose

OTC - PURPOSE SECTION

Relieve the itching, dry and scaling

Use

INDICATIONS & USAGE SECTION

Temporarily protects and helps relieveminor skin irritation and itching due to: PsoriasisEczema, Seborrheic Dermatitis, Molluscum,Shingles, Severe Boils, Fungal lnfections, Warts.Other Resistant Skin Conditions

Warnings

WARNINGS SECTION

For external use only.

WHEN USING SECTION

OTC - WHEN USING SECTION

Avoid contact with eyeslf contact occurs, rinse the eyes thoroughly with water

STOP USE section

OTC - STOP USE SECTION

Condition worsens ordoes not improve after regular use as directed

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, getmedical help or contact aPoison Control Center(1-800-222-1222) right away.

ASK DOCTOR

OTC - ASK DOCTOR SECTION

Apply a thin layer over the affected areatwice daily(morning and night), or asdirected by a doctor.
If the condition persists longer, consult a doctor.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply a small amount to theproblem areas with circularmotions for 3 minutes till theskin absorbs the cream.

Other information

STORAGE AND HANDLING SECTION

Store at 59-86ff(15-30°CClose the cap tightly after use.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Smilax Glabra, Sophora Flavescens, CnidiumMonnier(L) Cuss, Fructus Kochiae, Pseudolarixamabillis, Cortex Dictamni, Stemonatuberosalour, Mentha, Glycyrrhetinic Acid

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

81799-010-01

81799-010-0181799-010-01

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81799-010-012024-07-30C16284748780-11030e365-001a-111a-e063-dadaa90a10e281799-010
81799-010-012024-01-30C16284748780-11030e365-001a-111a-e063-dadaa90a10e281799-010

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81799-010-01Nupharmisto Psoriasis Eczema Cream100 mL in 1 BOTTLECREAM1002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81799-010NUPHARMISTO PSORIASIS ECZEMA CREAM (PSORIASIS ECZEMA CREAM) CREAM [EHY HOLDINGS LLC]21 package rows20230424_f6fbd22d-9f6a-0481-e053-6394a90aef02.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81799-01081799-010-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f9fd2aa7-1d4f-c3fc-e053-6294a90ae72bf6fbd22d-9f6a-0481-e053-6394a90aef022023-04-23WarningsExact identifier
spl id: f9fd2aa7-1d4f-c3fc-e053-6294a90ae72b
spl set id: f6fbd22d-9f6a-0481-e053-6394a90aef02

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.